nodes	percent_of_prediction	percent_of_DWPC	metapath
Treprostinil—PPARD—obesity	0.636	1	CbGaD
Treprostinil—CYP2C9—Phentermine—obesity	0.0421	0.404	CbGbCtD
Treprostinil—CYP2C9—Bupropion—obesity	0.0358	0.344	CbGbCtD
Treprostinil—CYP2C9—Cimetidine—obesity	0.0263	0.252	CbGbCtD
Treprostinil—PTGIR—hindbrain—obesity	0.003	0.114	CbGeAlD
Treprostinil—PPARD—islet of Langerhans—obesity	0.00253	0.0959	CbGeAlD
Treprostinil—P2RY12—cardiovascular system—obesity	0.0022	0.0835	CbGeAlD
Treprostinil—PTGIR—respiratory system—obesity	0.00183	0.0696	CbGeAlD
Treprostinil—PPARD—adipose tissue—obesity	0.00161	0.0612	CbGeAlD
Treprostinil—PPARD—digestive system—obesity	0.00152	0.0576	CbGeAlD
Treprostinil—P2RY12—endocrine gland—obesity	0.00151	0.0573	CbGeAlD
Treprostinil—PPARD—adrenal gland—obesity	0.00145	0.0549	CbGeAlD
Treprostinil—PTGIR—cardiovascular system—obesity	0.0014	0.0533	CbGeAlD
Treprostinil—Nadolol—ADRB3—obesity	0.00132	0.387	CrCbGaD
Treprostinil—PPARD—endocrine gland—obesity	0.00125	0.0476	CbGeAlD
Treprostinil—PTGIR—adipose tissue—obesity	0.00124	0.047	CbGeAlD
Treprostinil—PTGIR—digestive system—obesity	0.00116	0.0442	CbGeAlD
Treprostinil—PPARD—liver—obesity	0.00113	0.0429	CbGeAlD
Treprostinil—PTGIR—adrenal gland—obesity	0.00111	0.0421	CbGeAlD
Treprostinil—Latanoprost—SLC22A1—obesity	0.000991	0.29	CrCbGaD
Treprostinil—PTGIR—endocrine gland—obesity	0.000963	0.0365	CbGeAlD
Treprostinil—PTGIR—liver—obesity	0.000868	0.0329	CbGeAlD
Treprostinil—Nadolol—ADRB1—obesity	0.000597	0.175	CrCbGaD
Treprostinil—Nadolol—ADRB2—obesity	0.000502	0.147	CrCbGaD
Treprostinil—CYP2C9—cardiovascular system—obesity	0.000502	0.019	CbGeAlD
Treprostinil—CYP2C9—digestive system—obesity	0.000416	0.0158	CbGeAlD
Treprostinil—CYP2C9—endocrine gland—obesity	0.000344	0.0131	CbGeAlD
Treprostinil—Depression—Orlistat—obesity	0.00033	0.00292	CcSEcCtD
Treprostinil—Fatigue—Cimetidine—obesity	0.000329	0.00292	CcSEcCtD
Treprostinil—Pneumonia—Sibutramine—obesity	0.000322	0.00285	CcSEcCtD
Treprostinil—Urinary tract infection—Orlistat—obesity	0.000321	0.00285	CcSEcCtD
Treprostinil—Depression—Sibutramine—obesity	0.000319	0.00283	CcSEcCtD
Treprostinil—Dizziness—Phenylpropanolamine—obesity	0.000319	0.00282	CcSEcCtD
Treprostinil—Pulmonary embolism—Topiramate—obesity	0.000318	0.00281	CcSEcCtD
Treprostinil—Diarrhoea—Phentermine—obesity	0.000316	0.0028	CcSEcCtD
Treprostinil—Feeling abnormal—Cimetidine—obesity	0.000315	0.00279	CcSEcCtD
Treprostinil—Influenza—Bupropion—obesity	0.000313	0.00277	CcSEcCtD
Treprostinil—Urinary tract infection—Sibutramine—obesity	0.000311	0.00275	CcSEcCtD
Treprostinil—Melaena—Topiramate—obesity	0.00031	0.00275	CcSEcCtD
Treprostinil—Sinusitis—Orlistat—obesity	0.00031	0.00275	CcSEcCtD
Treprostinil—CYP2C9—liver—obesity	0.00031	0.0118	CbGeAlD
Treprostinil—Vomiting—Phenylpropanolamine—obesity	0.000307	0.00272	CcSEcCtD
Treprostinil—Dizziness—Phentermine—obesity	0.000305	0.0027	CcSEcCtD
Treprostinil—Haematuria—Sibutramine—obesity	0.000305	0.0027	CcSEcCtD
Treprostinil—Rash—Phenylpropanolamine—obesity	0.000304	0.00269	CcSEcCtD
Treprostinil—Dermatitis—Phenylpropanolamine—obesity	0.000304	0.00269	CcSEcCtD
Treprostinil—Body temperature increased—Cimetidine—obesity	0.000302	0.00267	CcSEcCtD
Treprostinil—Epistaxis—Sibutramine—obesity	0.000302	0.00267	CcSEcCtD
Treprostinil—Bronchitis—Bupropion—obesity	0.000301	0.00266	CcSEcCtD
Treprostinil—Sinusitis—Sibutramine—obesity	0.0003	0.00266	CcSEcCtD
Treprostinil—Abdominal discomfort—Bupropion—obesity	0.0003	0.00266	CcSEcCtD
Treprostinil—Haemoglobin—Orlistat—obesity	0.000298	0.00264	CcSEcCtD
Treprostinil—Haemorrhage—Orlistat—obesity	0.000297	0.00263	CcSEcCtD
Treprostinil—Pharyngitis—Orlistat—obesity	0.000295	0.00261	CcSEcCtD
Treprostinil—Vomiting—Phentermine—obesity	0.000293	0.0026	CcSEcCtD
Treprostinil—Bradycardia—Sibutramine—obesity	0.000292	0.00259	CcSEcCtD
Treprostinil—Oedema peripheral—Orlistat—obesity	0.000292	0.00259	CcSEcCtD
Treprostinil—Cramps of lower extremities—Topiramate—obesity	0.000292	0.00259	CcSEcCtD
Treprostinil—Rash—Phentermine—obesity	0.000291	0.00258	CcSEcCtD
Treprostinil—Dermatitis—Phentermine—obesity	0.000291	0.00257	CcSEcCtD
Treprostinil—Headache—Phentermine—obesity	0.000289	0.00256	CcSEcCtD
Treprostinil—Haemoglobin—Sibutramine—obesity	0.000289	0.00256	CcSEcCtD
Treprostinil—Rhinitis—Sibutramine—obesity	0.000288	0.00255	CcSEcCtD
Treprostinil—Haemorrhage—Sibutramine—obesity	0.000287	0.00254	CcSEcCtD
Treprostinil—Nausea—Phenylpropanolamine—obesity	0.000286	0.00254	CcSEcCtD
Treprostinil—Pharyngitis—Sibutramine—obesity	0.000285	0.00253	CcSEcCtD
Treprostinil—Oedema peripheral—Sibutramine—obesity	0.000283	0.00251	CcSEcCtD
Treprostinil—Pneumonia—Bupropion—obesity	0.000281	0.00249	CcSEcCtD
Treprostinil—Diarrhoea—Diethylpropion—obesity	0.000275	0.00243	CcSEcCtD
Treprostinil—Nausea—Phentermine—obesity	0.000274	0.00243	CcSEcCtD
Treprostinil—Asthenia—Cimetidine—obesity	0.000274	0.00243	CcSEcCtD
Treprostinil—Urinary tract infection—Bupropion—obesity	0.000271	0.0024	CcSEcCtD
Treprostinil—Dizziness—Diethylpropion—obesity	0.000265	0.00235	CcSEcCtD
Treprostinil—Epistaxis—Bupropion—obesity	0.000263	0.00233	CcSEcCtD
Treprostinil—Sinusitis—Bupropion—obesity	0.000262	0.00232	CcSEcCtD
Treprostinil—Diarrhoea—Cimetidine—obesity	0.000261	0.00231	CcSEcCtD
Treprostinil—Vomiting—Diethylpropion—obesity	0.000255	0.00226	CcSEcCtD
Treprostinil—Rash—Diethylpropion—obesity	0.000253	0.00224	CcSEcCtD
Treprostinil—Dermatitis—Diethylpropion—obesity	0.000253	0.00224	CcSEcCtD
Treprostinil—Dizziness—Cimetidine—obesity	0.000253	0.00224	CcSEcCtD
Treprostinil—Haemoglobin—Bupropion—obesity	0.000252	0.00223	CcSEcCtD
Treprostinil—Headache—Diethylpropion—obesity	0.000252	0.00223	CcSEcCtD
Treprostinil—Rhinitis—Bupropion—obesity	0.000251	0.00222	CcSEcCtD
Treprostinil—Haemorrhage—Bupropion—obesity	0.00025	0.00222	CcSEcCtD
Treprostinil—Back pain—Orlistat—obesity	0.00025	0.00221	CcSEcCtD
Treprostinil—Pharyngitis—Bupropion—obesity	0.000249	0.0022	CcSEcCtD
Treprostinil—Muscle spasms—Orlistat—obesity	0.000248	0.0022	CcSEcCtD
Treprostinil—Oedema peripheral—Bupropion—obesity	0.000247	0.00219	CcSEcCtD
Treprostinil—Tension—Sibutramine—obesity	0.000245	0.00217	CcSEcCtD
Treprostinil—Nervousness—Sibutramine—obesity	0.000243	0.00215	CcSEcCtD
Treprostinil—Vomiting—Cimetidine—obesity	0.000243	0.00215	CcSEcCtD
Treprostinil—Back pain—Sibutramine—obesity	0.000242	0.00214	CcSEcCtD
Treprostinil—Rash—Cimetidine—obesity	0.000241	0.00213	CcSEcCtD
Treprostinil—Dermatitis—Cimetidine—obesity	0.000241	0.00213	CcSEcCtD
Treprostinil—Muscle spasms—Sibutramine—obesity	0.00024	0.00213	CcSEcCtD
Treprostinil—Ill-defined disorder—Orlistat—obesity	0.00024	0.00212	CcSEcCtD
Treprostinil—Headache—Cimetidine—obesity	0.000239	0.00212	CcSEcCtD
Treprostinil—Nausea—Diethylpropion—obesity	0.000238	0.00211	CcSEcCtD
Treprostinil—Angioedema—Orlistat—obesity	0.000236	0.00209	CcSEcCtD
Treprostinil—Malaise—Orlistat—obesity	0.000233	0.00206	CcSEcCtD
Treprostinil—Flushing—Bupropion—obesity	0.000232	0.00206	CcSEcCtD
Treprostinil—Ill-defined disorder—Sibutramine—obesity	0.000232	0.00205	CcSEcCtD
Treprostinil—Anaemia—Sibutramine—obesity	0.000231	0.00205	CcSEcCtD
Treprostinil—Pain in extremity—Topiramate—obesity	0.000231	0.00204	CcSEcCtD
Treprostinil—Angioedema—Sibutramine—obesity	0.000229	0.00202	CcSEcCtD
Treprostinil—Palpitations—Orlistat—obesity	0.000228	0.00202	CcSEcCtD
Treprostinil—Nausea—Cimetidine—obesity	0.000227	0.00201	CcSEcCtD
Treprostinil—Malaise—Sibutramine—obesity	0.000226	0.002	CcSEcCtD
Treprostinil—Cough—Orlistat—obesity	0.000225	0.002	CcSEcCtD
Treprostinil—Syncope—Sibutramine—obesity	0.000224	0.00199	CcSEcCtD
Treprostinil—Palpitations—Sibutramine—obesity	0.000221	0.00196	CcSEcCtD
Treprostinil—Myalgia—Orlistat—obesity	0.00022	0.00195	CcSEcCtD
Treprostinil—Chest pain—Orlistat—obesity	0.00022	0.00195	CcSEcCtD
Treprostinil—Loss of consciousness—Sibutramine—obesity	0.00022	0.00195	CcSEcCtD
Treprostinil—Anxiety—Orlistat—obesity	0.000219	0.00194	CcSEcCtD
Treprostinil—Cough—Sibutramine—obesity	0.000218	0.00193	CcSEcCtD
Treprostinil—Discomfort—Orlistat—obesity	0.000217	0.00192	CcSEcCtD
Treprostinil—Dehydration—Topiramate—obesity	0.000214	0.0019	CcSEcCtD
Treprostinil—Tension—Bupropion—obesity	0.000214	0.00189	CcSEcCtD
Treprostinil—Chest pain—Sibutramine—obesity	0.000213	0.00189	CcSEcCtD
Treprostinil—Arthralgia—Sibutramine—obesity	0.000213	0.00189	CcSEcCtD
Treprostinil—Myalgia—Sibutramine—obesity	0.000213	0.00189	CcSEcCtD
Treprostinil—Anxiety—Sibutramine—obesity	0.000212	0.00188	CcSEcCtD
Treprostinil—Nervousness—Bupropion—obesity	0.000212	0.00188	CcSEcCtD
Treprostinil—Oedema—Orlistat—obesity	0.000211	0.00187	CcSEcCtD
Treprostinil—Back pain—Bupropion—obesity	0.000211	0.00187	CcSEcCtD
Treprostinil—Discomfort—Sibutramine—obesity	0.00021	0.00186	CcSEcCtD
Treprostinil—Hypokalaemia—Topiramate—obesity	0.00021	0.00186	CcSEcCtD
Treprostinil—Muscle spasms—Bupropion—obesity	0.00021	0.00186	CcSEcCtD
Treprostinil—Infection—Orlistat—obesity	0.00021	0.00186	CcSEcCtD
Treprostinil—Oedema—Sibutramine—obesity	0.000204	0.00181	CcSEcCtD
Treprostinil—Infection—Sibutramine—obesity	0.000203	0.0018	CcSEcCtD
Treprostinil—Ill-defined disorder—Bupropion—obesity	0.000202	0.00179	CcSEcCtD
Treprostinil—Anaemia—Bupropion—obesity	0.000202	0.00178	CcSEcCtD
Treprostinil—Shock—Sibutramine—obesity	0.000201	0.00178	CcSEcCtD
Treprostinil—Thrombocytopenia—Sibutramine—obesity	0.0002	0.00177	CcSEcCtD
Treprostinil—Angioedema—Bupropion—obesity	0.000199	0.00176	CcSEcCtD
Treprostinil—Tachycardia—Sibutramine—obesity	0.000199	0.00176	CcSEcCtD
Treprostinil—Malaise—Bupropion—obesity	0.000197	0.00174	CcSEcCtD
Treprostinil—Syncope—Bupropion—obesity	0.000196	0.00173	CcSEcCtD
Treprostinil—Anorexia—Sibutramine—obesity	0.000195	0.00172	CcSEcCtD
Treprostinil—Palpitations—Bupropion—obesity	0.000193	0.00171	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Orlistat—obesity	0.000192	0.0017	CcSEcCtD
Treprostinil—Bronchitis—Topiramate—obesity	0.000192	0.0017	CcSEcCtD
Treprostinil—Loss of consciousness—Bupropion—obesity	0.000192	0.0017	CcSEcCtD
Treprostinil—Abdominal discomfort—Topiramate—obesity	0.000191	0.00169	CcSEcCtD
Treprostinil—Insomnia—Orlistat—obesity	0.000191	0.00169	CcSEcCtD
Treprostinil—Hypotension—Sibutramine—obesity	0.000191	0.00169	CcSEcCtD
Treprostinil—Cough—Bupropion—obesity	0.00019	0.00168	CcSEcCtD
Treprostinil—Paraesthesia—Orlistat—obesity	0.000189	0.00168	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Sibutramine—obesity	0.000186	0.00165	CcSEcCtD
Treprostinil—Dyspepsia—Orlistat—obesity	0.000186	0.00164	CcSEcCtD
Treprostinil—Myalgia—Bupropion—obesity	0.000186	0.00164	CcSEcCtD
Treprostinil—Arthralgia—Bupropion—obesity	0.000186	0.00164	CcSEcCtD
Treprostinil—Chest pain—Bupropion—obesity	0.000186	0.00164	CcSEcCtD
Treprostinil—Anxiety—Bupropion—obesity	0.000185	0.00164	CcSEcCtD
Treprostinil—Insomnia—Sibutramine—obesity	0.000185	0.00163	CcSEcCtD
Treprostinil—Discomfort—Bupropion—obesity	0.000183	0.00162	CcSEcCtD
Treprostinil—Decreased appetite—Orlistat—obesity	0.000183	0.00162	CcSEcCtD
Treprostinil—Paraesthesia—Sibutramine—obesity	0.000183	0.00162	CcSEcCtD
Treprostinil—Dyspnoea—Sibutramine—obesity	0.000182	0.00161	CcSEcCtD
Treprostinil—Fatigue—Orlistat—obesity	0.000182	0.00161	CcSEcCtD
Treprostinil—Pain—Orlistat—obesity	0.00018	0.0016	CcSEcCtD
Treprostinil—Dyspepsia—Sibutramine—obesity	0.00018	0.00159	CcSEcCtD
Treprostinil—Pneumonia—Topiramate—obesity	0.000179	0.00158	CcSEcCtD
Treprostinil—Oedema—Bupropion—obesity	0.000178	0.00158	CcSEcCtD
Treprostinil—Decreased appetite—Sibutramine—obesity	0.000177	0.00157	CcSEcCtD
Treprostinil—Depression—Topiramate—obesity	0.000177	0.00157	CcSEcCtD
Treprostinil—Infection—Bupropion—obesity	0.000177	0.00157	CcSEcCtD
Treprostinil—Shock—Bupropion—obesity	0.000175	0.00155	CcSEcCtD
Treprostinil—Pain—Sibutramine—obesity	0.000175	0.00155	CcSEcCtD
Treprostinil—Thrombocytopenia—Bupropion—obesity	0.000174	0.00154	CcSEcCtD
Treprostinil—Feeling abnormal—Orlistat—obesity	0.000174	0.00154	CcSEcCtD
Treprostinil—Tachycardia—Bupropion—obesity	0.000174	0.00154	CcSEcCtD
Treprostinil—Urinary tract infection—Topiramate—obesity	0.000173	0.00153	CcSEcCtD
Treprostinil—Gastrointestinal pain—Orlistat—obesity	0.000172	0.00153	CcSEcCtD
Treprostinil—Anorexia—Bupropion—obesity	0.00017	0.0015	CcSEcCtD
Treprostinil—Haematuria—Topiramate—obesity	0.000169	0.0015	CcSEcCtD
Treprostinil—Feeling abnormal—Sibutramine—obesity	0.000168	0.00149	CcSEcCtD
Treprostinil—Epistaxis—Topiramate—obesity	0.000168	0.00148	CcSEcCtD
Treprostinil—Gastrointestinal pain—Sibutramine—obesity	0.000167	0.00148	CcSEcCtD
Treprostinil—Sinusitis—Topiramate—obesity	0.000167	0.00148	CcSEcCtD
Treprostinil—Abdominal pain—Orlistat—obesity	0.000167	0.00148	CcSEcCtD
Treprostinil—Body temperature increased—Orlistat—obesity	0.000167	0.00148	CcSEcCtD
Treprostinil—Hypotension—Bupropion—obesity	0.000166	0.00147	CcSEcCtD
Treprostinil—Bradycardia—Topiramate—obesity	0.000162	0.00144	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Bupropion—obesity	0.000162	0.00144	CcSEcCtD
Treprostinil—Abdominal pain—Sibutramine—obesity	0.000161	0.00143	CcSEcCtD
Treprostinil—Body temperature increased—Sibutramine—obesity	0.000161	0.00143	CcSEcCtD
Treprostinil—Insomnia—Bupropion—obesity	0.000161	0.00143	CcSEcCtD
Treprostinil—Haemoglobin—Topiramate—obesity	0.00016	0.00142	CcSEcCtD
Treprostinil—Rhinitis—Topiramate—obesity	0.00016	0.00142	CcSEcCtD
Treprostinil—Paraesthesia—Bupropion—obesity	0.00016	0.00141	CcSEcCtD
Treprostinil—Haemorrhage—Topiramate—obesity	0.00016	0.00141	CcSEcCtD
Treprostinil—Dyspnoea—Bupropion—obesity	0.000159	0.0014	CcSEcCtD
Treprostinil—Pharyngitis—Topiramate—obesity	0.000158	0.0014	CcSEcCtD
Treprostinil—Oedema peripheral—Topiramate—obesity	0.000157	0.00139	CcSEcCtD
Treprostinil—Dyspepsia—Bupropion—obesity	0.000157	0.00139	CcSEcCtD
Treprostinil—Decreased appetite—Bupropion—obesity	0.000155	0.00137	CcSEcCtD
Treprostinil—Fatigue—Bupropion—obesity	0.000153	0.00136	CcSEcCtD
Treprostinil—Pain—Bupropion—obesity	0.000152	0.00135	CcSEcCtD
Treprostinil—Asthenia—Orlistat—obesity	0.000151	0.00134	CcSEcCtD
Treprostinil—Pruritus—Orlistat—obesity	0.000149	0.00132	CcSEcCtD
Treprostinil—Flushing—Topiramate—obesity	0.000148	0.00131	CcSEcCtD
Treprostinil—Feeling abnormal—Bupropion—obesity	0.000147	0.0013	CcSEcCtD
Treprostinil—Asthenia—Sibutramine—obesity	0.000146	0.0013	CcSEcCtD
Treprostinil—Gastrointestinal pain—Bupropion—obesity	0.000145	0.00129	CcSEcCtD
Treprostinil—Pruritus—Sibutramine—obesity	0.000144	0.00128	CcSEcCtD
Treprostinil—Diarrhoea—Orlistat—obesity	0.000144	0.00128	CcSEcCtD
Treprostinil—Body temperature increased—Bupropion—obesity	0.000141	0.00125	CcSEcCtD
Treprostinil—Abdominal pain—Bupropion—obesity	0.000141	0.00125	CcSEcCtD
Treprostinil—Diarrhoea—Sibutramine—obesity	0.00014	0.00124	CcSEcCtD
Treprostinil—Dizziness—Orlistat—obesity	0.000139	0.00124	CcSEcCtD
Treprostinil—Erythema—Topiramate—obesity	0.000139	0.00123	CcSEcCtD
Treprostinil—Tension—Topiramate—obesity	0.000136	0.00121	CcSEcCtD
Treprostinil—Dizziness—Sibutramine—obesity	0.000135	0.0012	CcSEcCtD
Treprostinil—Nervousness—Topiramate—obesity	0.000135	0.00119	CcSEcCtD
Treprostinil—Back pain—Topiramate—obesity	0.000134	0.00119	CcSEcCtD
Treprostinil—Vomiting—Orlistat—obesity	0.000134	0.00119	CcSEcCtD
Treprostinil—Muscle spasms—Topiramate—obesity	0.000134	0.00118	CcSEcCtD
Treprostinil—Rash—Orlistat—obesity	0.000133	0.00118	CcSEcCtD
Treprostinil—Dermatitis—Orlistat—obesity	0.000133	0.00118	CcSEcCtD
Treprostinil—Headache—Orlistat—obesity	0.000132	0.00117	CcSEcCtD
Treprostinil—Vomiting—Sibutramine—obesity	0.00013	0.00115	CcSEcCtD
Treprostinil—Ill-defined disorder—Topiramate—obesity	0.000129	0.00114	CcSEcCtD
Treprostinil—Rash—Sibutramine—obesity	0.000129	0.00114	CcSEcCtD
Treprostinil—Dermatitis—Sibutramine—obesity	0.000129	0.00114	CcSEcCtD
Treprostinil—Anaemia—Topiramate—obesity	0.000128	0.00114	CcSEcCtD
Treprostinil—Headache—Sibutramine—obesity	0.000128	0.00113	CcSEcCtD
Treprostinil—Asthenia—Bupropion—obesity	0.000128	0.00113	CcSEcCtD
Treprostinil—Pruritus—Bupropion—obesity	0.000126	0.00111	CcSEcCtD
Treprostinil—Nausea—Orlistat—obesity	0.000125	0.00111	CcSEcCtD
Treprostinil—Malaise—Topiramate—obesity	0.000125	0.00111	CcSEcCtD
Treprostinil—Syncope—Topiramate—obesity	0.000125	0.0011	CcSEcCtD
Treprostinil—Palpitations—Topiramate—obesity	0.000123	0.00109	CcSEcCtD
Treprostinil—Loss of consciousness—Topiramate—obesity	0.000122	0.00108	CcSEcCtD
Treprostinil—Diarrhoea—Bupropion—obesity	0.000122	0.00108	CcSEcCtD
Treprostinil—Nausea—Sibutramine—obesity	0.000121	0.00107	CcSEcCtD
Treprostinil—Cough—Topiramate—obesity	0.000121	0.00107	CcSEcCtD
Treprostinil—Arthralgia—Topiramate—obesity	0.000118	0.00105	CcSEcCtD
Treprostinil—Chest pain—Topiramate—obesity	0.000118	0.00105	CcSEcCtD
Treprostinil—Myalgia—Topiramate—obesity	0.000118	0.00105	CcSEcCtD
Treprostinil—Anxiety—Topiramate—obesity	0.000118	0.00104	CcSEcCtD
Treprostinil—Dizziness—Bupropion—obesity	0.000118	0.00104	CcSEcCtD
Treprostinil—Discomfort—Topiramate—obesity	0.000117	0.00103	CcSEcCtD
Treprostinil—Oedema—Topiramate—obesity	0.000113	0.001	CcSEcCtD
Treprostinil—Vomiting—Bupropion—obesity	0.000113	0.001	CcSEcCtD
Treprostinil—Infection—Topiramate—obesity	0.000113	0.000997	CcSEcCtD
Treprostinil—Rash—Bupropion—obesity	0.000112	0.000994	CcSEcCtD
Treprostinil—Dermatitis—Bupropion—obesity	0.000112	0.000993	CcSEcCtD
Treprostinil—Shock—Topiramate—obesity	0.000112	0.000988	CcSEcCtD
Treprostinil—Headache—Bupropion—obesity	0.000111	0.000987	CcSEcCtD
Treprostinil—Thrombocytopenia—Topiramate—obesity	0.000111	0.000983	CcSEcCtD
Treprostinil—Tachycardia—Topiramate—obesity	0.000111	0.00098	CcSEcCtD
Treprostinil—Anorexia—Topiramate—obesity	0.000108	0.000957	CcSEcCtD
Treprostinil—Hypotension—Topiramate—obesity	0.000106	0.000938	CcSEcCtD
Treprostinil—Nausea—Bupropion—obesity	0.000106	0.000936	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Topiramate—obesity	0.000103	0.000915	CcSEcCtD
Treprostinil—Insomnia—Topiramate—obesity	0.000103	0.000908	CcSEcCtD
Treprostinil—Paraesthesia—Topiramate—obesity	0.000102	0.000901	CcSEcCtD
Treprostinil—Dyspnoea—Topiramate—obesity	0.000101	0.000895	CcSEcCtD
Treprostinil—Dyspepsia—Topiramate—obesity	9.98e-05	0.000884	CcSEcCtD
Treprostinil—Decreased appetite—Topiramate—obesity	9.85e-05	0.000873	CcSEcCtD
Treprostinil—Fatigue—Topiramate—obesity	9.77e-05	0.000866	CcSEcCtD
Treprostinil—Pain—Topiramate—obesity	9.69e-05	0.000859	CcSEcCtD
Treprostinil—Feeling abnormal—Topiramate—obesity	9.34e-05	0.000827	CcSEcCtD
Treprostinil—Gastrointestinal pain—Topiramate—obesity	9.27e-05	0.000821	CcSEcCtD
Treprostinil—Body temperature increased—Topiramate—obesity	8.96e-05	0.000794	CcSEcCtD
Treprostinil—Abdominal pain—Topiramate—obesity	8.96e-05	0.000794	CcSEcCtD
Treprostinil—Asthenia—Topiramate—obesity	8.13e-05	0.00072	CcSEcCtD
Treprostinil—Pruritus—Topiramate—obesity	8.02e-05	0.00071	CcSEcCtD
Treprostinil—Diarrhoea—Topiramate—obesity	7.76e-05	0.000687	CcSEcCtD
Treprostinil—Dizziness—Topiramate—obesity	7.5e-05	0.000664	CcSEcCtD
Treprostinil—Vomiting—Topiramate—obesity	7.21e-05	0.000638	CcSEcCtD
Treprostinil—Rash—Topiramate—obesity	7.15e-05	0.000633	CcSEcCtD
Treprostinil—Dermatitis—Topiramate—obesity	7.14e-05	0.000632	CcSEcCtD
Treprostinil—Headache—Topiramate—obesity	7.1e-05	0.000629	CcSEcCtD
Treprostinil—Nausea—Topiramate—obesity	6.73e-05	0.000596	CcSEcCtD
Treprostinil—PTGIR—Signaling Pathways—GNAS—obesity	1.27e-05	0.000108	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PIK3CB—obesity	1.27e-05	0.000108	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PIK3R1—obesity	1.26e-05	0.000107	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PNPLA3—obesity	1.24e-05	0.000106	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—COX7C—obesity	1.24e-05	0.000106	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—UCP1—obesity	1.24e-05	0.000106	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—APOB—obesity	1.24e-05	0.000106	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—PIK3CA—obesity	1.24e-05	0.000105	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.24e-05	0.000105	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCL5—obesity	1.21e-05	0.000103	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PRKCD—obesity	1.19e-05	0.000101	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—LPL—obesity	1.19e-05	0.000101	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CPT1A—obesity	1.18e-05	0.000101	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CS—obesity	1.18e-05	0.0001	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—DGAT2—obesity	1.18e-05	0.0001	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CPS1—obesity	1.18e-05	0.0001	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SUCLA2—obesity	1.18e-05	0.0001	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PIK3CG—obesity	1.18e-05	0.0001	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—FOXO1—obesity	1.18e-05	0.0001	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—RPS6KB1—obesity	1.18e-05	0.0001	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PIK3CB—obesity	1.16e-05	9.9e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—HTR2A—obesity	1.16e-05	9.89e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—C3—obesity	1.16e-05	9.87e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—obesity	1.15e-05	9.8e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—obesity	1.15e-05	9.74e-05	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PPARG—obesity	1.14e-05	9.67e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—LIPE—obesity	1.13e-05	9.57e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—MUT—obesity	1.13e-05	9.57e-05	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—POMC—obesity	1.12e-05	9.54e-05	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—INS—obesity	1.12e-05	9.49e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CETP—obesity	1.11e-05	9.46e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IRS2—obesity	1.1e-05	9.39e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—AGT—obesity	1.1e-05	9.38e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—SDC1—obesity	1.1e-05	9.35e-05	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—AKT1—obesity	1.1e-05	9.34e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PRKCD—obesity	1.09e-05	9.3e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—obesity	1.08e-05	9.2e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—LEP—obesity	1.08e-05	9.19e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—APOE—obesity	1.08e-05	9.19e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYB5A—obesity	1.08e-05	9.17e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—DGAT1—obesity	1.08e-05	9.17e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CAV1—obesity	1.07e-05	9.11e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HTR2A—obesity	1.07e-05	9.1e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—C3—obesity	1.07e-05	9.09e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—APOA1—obesity	1.07e-05	9.09e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—obesity	1.07e-05	9.06e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ACLY—obesity	1.04e-05	8.83e-05	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PIK3CD—obesity	1.04e-05	8.81e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—SREBF1—obesity	1.03e-05	8.79e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ESR1—obesity	1.03e-05	8.77e-05	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ALB—obesity	1.02e-05	8.7e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—F2—obesity	1.02e-05	8.67e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PRKCB—obesity	1.02e-05	8.67e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IRS2—obesity	1.02e-05	8.64e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—AGT—obesity	1.02e-05	8.63e-05	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—AKT1—obesity	1.01e-05	8.59e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—BAD—obesity	1.01e-05	8.56e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ENPP1—obesity	1e-05	8.53e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ALOX12—obesity	1e-05	8.53e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—LEP—obesity	9.95e-06	8.46e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—APOE—obesity	9.95e-06	8.46e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CAV1—obesity	9.86e-06	8.38e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—FASN—obesity	9.85e-06	8.37e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—APOA1—obesity	9.84e-06	8.36e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—obesity	9.8e-06	8.34e-05	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—NOS3—obesity	9.79e-06	8.32e-05	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PIK3R1—obesity	9.79e-06	8.32e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PIK3CG—obesity	9.76e-06	8.29e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HMGCS1—obesity	9.72e-06	8.26e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IRS1—obesity	9.64e-06	8.2e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ESR1—obesity	9.5e-06	8.08e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SAT1—obesity	9.43e-06	8.02e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ANGPTL4—obesity	9.43e-06	8.02e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ACADM—obesity	9.43e-06	8.02e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PFKFB3—obesity	9.43e-06	8.02e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PLIN1—obesity	9.43e-06	8.02e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PNPLA2—obesity	9.43e-06	8.02e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PRKCB—obesity	9.38e-06	7.98e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—F2—obesity	9.38e-06	7.98e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—POMC—obesity	9.29e-06	7.9e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—BAD—obesity	9.27e-06	7.88e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—INS—obesity	9.24e-06	7.85e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—OXCT1—obesity	9.17e-06	7.8e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYTB—obesity	9.17e-06	7.8e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ACACB—obesity	9.17e-06	7.8e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCL2—obesity	9.09e-06	7.72e-05	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PIK3CB—obesity	9.03e-06	7.68e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PIK3CG—obesity	8.98e-06	7.63e-05	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PTGS2—obesity	8.95e-06	7.61e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PNLIP—obesity	8.94e-06	7.6e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SRD5A1—obesity	8.94e-06	7.6e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IGF1—obesity	8.93e-06	7.59e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—AKT2—obesity	8.93e-06	7.59e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IRS1—obesity	8.88e-06	7.55e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SDC3—obesity	8.73e-06	7.42e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—obesity	8.68e-06	7.38e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PIK3CD—obesity	8.58e-06	7.29e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—NCOA1—obesity	8.55e-06	7.27e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—POMC—obesity	8.55e-06	7.27e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYP26B1—obesity	8.53e-06	7.25e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—STS—obesity	8.53e-06	7.25e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HK2—obesity	8.53e-06	7.25e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—INS—obesity	8.5e-06	7.23e-05	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—PIK3CA—obesity	8.5e-06	7.22e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SERPINE1—obesity	8.48e-06	7.21e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—obesity	8.43e-06	7.17e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCL2—obesity	8.36e-06	7.11e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PPARD—obesity	8.35e-06	7.1e-05	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—MYC—obesity	8.34e-06	7.09e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TYK2—obesity	8.25e-06	7.01e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IGF1—obesity	8.22e-06	6.99e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—AKT2—obesity	8.22e-06	6.98e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—RHOA—obesity	8.18e-06	6.96e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SLC27A1—obesity	8.18e-06	6.95e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PIK3R1—obesity	8.1e-06	6.89e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NOS3—obesity	8.1e-06	6.89e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—FABP4—obesity	8.02e-06	6.82e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GLUL—obesity	8.02e-06	6.82e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PIK3CD—obesity	7.89e-06	6.71e-05	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—PIK3CA—obesity	7.82e-06	6.65e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SERPINE1—obesity	7.81e-06	6.64e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—obesity	7.73e-06	6.57e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PIK3CA—obesity	7.71e-06	6.56e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ECHS1—obesity	7.6e-06	6.46e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HSD11B1—obesity	7.6e-06	6.46e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—UCP2—obesity	7.6e-06	6.46e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—UCP3—obesity	7.6e-06	6.46e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TYK2—obesity	7.59e-06	6.46e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—RHOA—obesity	7.53e-06	6.4e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ADH1B—obesity	7.48e-06	6.36e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MTOR—obesity	7.48e-06	6.36e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PIK3CB—obesity	7.48e-06	6.36e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PIK3R1—obesity	7.45e-06	6.34e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NOS3—obesity	7.45e-06	6.34e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—APOB—obesity	7.37e-06	6.26e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GPAM—obesity	7.36e-06	6.26e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ACSL1—obesity	7.36e-06	6.26e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PPARGC1B—obesity	7.36e-06	6.26e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—FADS1—obesity	7.15e-06	6.08e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HADH—obesity	7.15e-06	6.08e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PCK1—obesity	7.15e-06	6.08e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PIK3CA—obesity	7.1e-06	6.04e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—LPL—obesity	7.04e-06	5.98e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ACP5—obesity	6.95e-06	5.91e-05	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—AKT1—obesity	6.94e-06	5.9e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PIK3CB—obesity	6.88e-06	5.85e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MTOR—obesity	6.88e-06	5.85e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—obesity	6.87e-06	5.84e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL6—obesity	6.83e-06	5.81e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—G6PD—obesity	6.78e-06	5.76e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HK1—obesity	6.69e-06	5.69e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SREBF2—obesity	6.69e-06	5.69e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CD36—obesity	6.69e-06	5.68e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MMP9—obesity	6.5e-06	5.52e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—LPA—obesity	6.46e-06	5.5e-05	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—AKT1—obesity	6.39e-06	5.43e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—LPIN1—obesity	6.33e-06	5.38e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MAPK8—obesity	6.32e-06	5.37e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—AKT1—obesity	6.3e-06	5.36e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—IL6—obesity	6.29e-06	5.34e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—obesity	6.22e-06	5.28e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—APOA5—obesity	6.2e-06	5.27e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—AGT—obesity	6.02e-06	5.12e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MMP9—obesity	5.98e-06	5.08e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CLOCK—obesity	5.91e-06	5.03e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SLC22A1—obesity	5.91e-06	5.03e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—obesity	5.9e-06	5.01e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—obesity	5.84e-06	4.97e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—obesity	5.83e-06	4.96e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MAPK8—obesity	5.82e-06	4.94e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—AKT1—obesity	5.8e-06	4.93e-05	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—AKT1—obesity	5.79e-06	4.92e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—STAT3—obesity	5.78e-06	4.91e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SULT2A1—obesity	5.76e-06	4.9e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GLP1R—obesity	5.76e-06	4.9e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—DPYD—obesity	5.67e-06	4.82e-05	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PIK3CA—obesity	5.51e-06	4.68e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PRKAR2B—obesity	5.46e-06	4.64e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—DCN—obesity	5.42e-06	4.61e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MYC—obesity	5.37e-06	4.56e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TGFB1—obesity	5.36e-06	4.55e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—obesity	5.32e-06	4.53e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—STAT3—obesity	5.32e-06	4.52e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CPT1A—obesity	5.27e-06	4.48e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—NAMPT—obesity	5.17e-06	4.39e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—obesity	5.14e-06	4.37e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—LIPC—obesity	5.14e-06	4.37e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GCK—obesity	5.14e-06	4.37e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—APOC3—obesity	5.1e-06	4.34e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—POMC—obesity	5.07e-06	4.31e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CETP—obesity	4.95e-06	4.21e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MYC—obesity	4.94e-06	4.2e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TGFB1—obesity	4.93e-06	4.19e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SDC1—obesity	4.9e-06	4.16e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—AKR1C3—obesity	4.82e-06	4.1e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SCARB1—obesity	4.74e-06	4.03e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—obesity	4.68e-06	3.98e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—obesity	4.62e-06	3.93e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SREBF1—obesity	4.61e-06	3.92e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PIK3CA—obesity	4.56e-06	3.87e-05	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—AKT1—obesity	4.5e-06	3.82e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GOT2—obesity	4.48e-06	3.81e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—obesity	4.42e-06	3.76e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—FASN—obesity	4.38e-06	3.73e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—BCHE—obesity	4.37e-06	3.71e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYP2E1—obesity	4.21e-06	3.58e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PIK3CA—obesity	4.19e-06	3.57e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—NQO1—obesity	4.17e-06	3.54e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—obesity	4.08e-06	3.47e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—obesity	4.04e-06	3.44e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL6—obesity	4.04e-06	3.43e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GCG—obesity	3.99e-06	3.4e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SLC2A4—obesity	3.99e-06	3.4e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYCS—obesity	3.94e-06	3.35e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GOT1—obesity	3.87e-06	3.29e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GGT1—obesity	3.87e-06	3.29e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—NCOA1—obesity	3.81e-06	3.24e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—STK11—obesity	3.75e-06	3.19e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYP19A1—obesity	3.75e-06	3.19e-05	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—AKT1—obesity	3.72e-06	3.16e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL6—obesity	3.71e-06	3.16e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—COMT—obesity	3.49e-06	2.97e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PPARGC1A—obesity	3.44e-06	2.93e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GNB3—obesity	3.44e-06	2.93e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HMOX1—obesity	3.43e-06	2.91e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—AKT1—obesity	3.43e-06	2.91e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GNAS—obesity	3.35e-06	2.85e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—APOB—obesity	3.28e-06	2.79e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—LPL—obesity	3.13e-06	2.66e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GPX1—obesity	3.06e-06	2.6e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CD36—obesity	2.98e-06	2.53e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—MTHFR—obesity	2.82e-06	2.4e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PPARA—obesity	2.77e-06	2.35e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—AGT—obesity	2.68e-06	2.28e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—APOE—obesity	2.63e-06	2.23e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CAV1—obesity	2.6e-06	2.21e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—APOA1—obesity	2.6e-06	2.21e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.49e-06	2.11e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PIK3CG—obesity	2.37e-06	2.02e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PPARG—obesity	2.29e-06	1.95e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—POMC—obesity	2.26e-06	1.92e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—INS—obesity	2.24e-06	1.91e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PIK3CD—obesity	2.08e-06	1.77e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ALB—obesity	2.06e-06	1.75e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PIK3R1—obesity	1.97e-06	1.67e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—NOS3—obesity	1.97e-06	1.67e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PIK3CB—obesity	1.82e-06	1.54e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PTGS2—obesity	1.8e-06	1.53e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PIK3CA—obesity	1.11e-06	9.41e-06	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—AKT1—obesity	9.05e-07	7.69e-06	CbGpPWpGaD
